News Releases

SenesTech Signs Poppe Enterprises for Evolve™ Distribution in Grain Management Market

PHOENIX, Jan. 29, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces a signed distribution agreement with Poppe Enterprises LLC, a distributor and pest management firm focused on the grain management market, serving Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa and Colorado. Poppe Enterprises will be a stocking distributor for Evolve™ soft bait and has placed its initial stocking order.

Joel Fruendt, SenesTech's President and CEO, said: "Grain storage operations have unique challenges when it comes to rodent pest control. Poisons are highly regulated and are tricky to use without contamination, and traps are expensive and time-consuming to maintain. The non-poison Evolve soft bait, with its minimum risk EPA designation, reasonable cost, and proven efficacy, provides a new tool for this widespread market.

"We are partnering with a leader and innovator in grain management and pest control, Poppe Enterprises. Poppe Enterprises has a keen focus on innovation, safety, and sustainability, and a strong reputation in this substantial market. Their presence and market knowledge will mean immediate penetration of the Evolve product."

Evolve addresses the fundamental issue of rodent overpopulation by focusing on the rapid reproduction of rats. Evolve controls the population by reducing or eliminating the fertility of rats, rather than trying to keep up with the growing numbers of an infestation with poisons alone. The active ingredient in Evolve effectively reduced fertility in rodents in numerous independent studies. Evolve is highly palatable to rats, easy to deploy, offers diverse placement in many different environments and is priced competitively to rodenticide alternatives.

The grain market represents a significant opportunity for Evolve. Rodents are responsible for destroying nearly 20% of the world's stored food supply due to consumption and contamination.

About SenesTech
We are committed to improving the health of the world by humanely managing animal pest populations, applying our expertise in fertility control. We invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.

For more information visit and

Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Poppe Enterprises' market presence and knowledge will mean immediate penetration of the Evolve product and our belief that the grain market represents a significant opportunity for Evolve. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the impacts and implications of the COVID-19 pandemic, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC,

Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,
928-779-4143 x825

SOURCE SenesTech, Inc.